Larimar Therapeutics (LRMR) Provides Nomlabofusp Development Update

Go back to Larimar Therapeutics (LRMR) Provides Nomlabofusp Development Update
(NASDAQ: LRMR) Delayed: 3.61 +0.20 (5.87%)
Previous Close $3.41    52 Week High
Open $3.42    52 Week Low
Day High $3.64    P/E N/A 
Day Low $3.41    EPS
Volume 2,050,231